vimarsana.com
Home
Live Updates
AxioMed LLC Files PMA Module II of III targeting 2022 FDA Ap
AxioMed LLC Files PMA Module II of III targeting 2022 FDA Ap
AxioMed LLC Files PMA Module II of III targeting 2022 FDA Approval of The First and Only Viscoelastic Lumbar Disc Replacement to Complete an IDE Clinical Study
Malden, MA (PRWEB) February 02, 2022 -- AxioMed's lumbar viscoelastic total disc replacement PMA Module II was submitted to the FDA on January 28th,
Related Keywords
Australia ,
United States ,
Erik Spayde ,
William Costigan ,
John Sullivan ,
Kingsleyr Chin ,
Aditya Humad ,
Global Quality Affairs ,
Kicventures Group ,
Chief Technology Officer ,
Vito Lore ,
Regulatory Compliance ,
Chief Financial Officer ,
Cleveland Clinic ,
Art Steffee ,
Axiomed Viscoelastic Disc Technologies ,
Press Release ,